Kala Bio (KALA) Amortization of Deferred Charges (2016 - 2025)

Kala Bio has reported Amortization of Deferred Charges for 10 years, with the latest figure at -$1.1 million in Q4 2025.

• Quarterly Amortization of Deferred Charges fell 481.94% year-over-year to -$1.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$667000.0 (down 153.45% YoY) and the FY2025 annual result came in at -$667000.0, down 153.45% from the prior year.
• Amortization of Deferred Charges eased to -$1.1 million in Q4 2025 per KALA's latest filing, from $116000.0 in the prior quarter.
• Over five years, Amortization of Deferred Charges peaked at $439000.0 in Q4 2021 and troughed at -$1.1 million in Q4 2025.
• A 5-year average of $238900.0 and a median of $310500.0 in 2023 frame the typical range for Amortization of Deferred Charges.
• The sharpest annual moves came in 2021 and 2025: Amortization of Deferred Charges jumped 61.71% in 2021, then slumped 481.94% in 2025.
• Over 5 years, Amortization of Deferred Charges stood at $439000.0 in 2021, then tumbled by 32.8% to $295000.0 in 2022, then climbed by 5.76% to $312000.0 in 2023, then fell by 4.17% to $299000.0 in 2024, then plunged by 481.94% to -$1.1 million in 2025.
• According to Business Quant data, Amortization of Deferred Charges over the past three periods registered -$1.1 million, $116000.0, and $173000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.